Delivery Order SPE2DX22D0040-SPE2D825FA4DU

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $8.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DX22D0059|SPE2D825F0CQE was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,471.37 firm fixed-price delivery order contract has a completion date of January 14, 2025 and covers the supply of various pharmaceutical products and medical supplies to support military healthcare programs globally. This award is associated with...
The federal contract award, SPE2DX22D0019|SPE2D825FAX61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,716.26 firm fixed-price delivery order contract has a completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award, with ID SPE2DX22D0029|SPE2D825F10GS, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,190.36 firm-fixed-price delivery order contract has an ultimate completion date of December 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. It is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award, with ID SPE2DX22D0019|SPE2D825FDE19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,854.62 firm fixed-price delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,023.11 firm-fixed-price delivery order, with a completion date of September 18, 2023, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen by the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The federal contract award, with ID SPE2DX22D0019|SPE2D825FCJ10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,452.84 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
This federal contract award SPE2DX22D0029|SPE2D825F14TG was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,035.56 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award, with ID SPE2DX22D0020|SPE2D825F04PG, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,539.50 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, with ID SPE2DX22D0020|SPE2D825F15NB, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,133.44 firm-fixed-price delivery order contract is not designated with a set-aside requirement, indicating open competition. The award falls under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
The federal contract award SPE2DX22D0049|SPE2D825FA3EW was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,560.93 firm fixed-price delivery order contract has an ultimate completion date of January 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DX22D0040
    Indefinite Delivery Contract
  • SPE2DX22D0040-SPE2D825FA4DU
    Delivery Order

This federal contract award, with ID SPE2DX22D0040|SPE2D825FA4DU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,812.34 fixed-price delivery order contract, which has no set-aside designation, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has an ultimate completion date of February 24, 2025.

Generated 5/23/25, 9:42 AM